Scotch Plains, NJ, United States of America

Dennis M Zaller

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 187(Granted Patents)


Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Dennis M Zaller: Innovator in Antibody Therapeutics

Introduction

Dennis M Zaller is a prominent inventor based in Scotch Plains, NJ (US), known for his significant contributions to the field of antibody therapeutics. With a total of 10 patents to his name, Zaller has made remarkable advancements in the treatment of conditions associated with interleukin-13 receptor alpha 1.

Latest Patents

Zaller's latest patents focus on high affinity antibody antagonists of interleukin-13 receptor alpha 1. These antibody molecules are effective in inhibiting IL-13Rα1-mediated activities, making them desirable antagonists for treating conditions linked to hIL-13Rα1 activity. The patents also disclose nucleic acids encoding these antibody molecules, vectors, host cells, and compositions that include the antibody molecules. Furthermore, methods for using these antibody molecules to inhibit or antagonize IL-13Rα1-mediated activities are also detailed in his patents.

Career Highlights

Throughout his career, Zaller has worked with notable companies such as CSL Limited and Merck & Company, Inc. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Zaller has collaborated with esteemed colleagues, including Andrew Donald Nash and Louis Jerry Fabri, further enhancing his work in the field of antibody therapeutics.

Conclusion

Dennis M Zaller's contributions to the field of antibody therapeutics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…